HOUSE 3808117th CongressReferred to the Subcommittee on Health.
Medicare IVIG Access Enhancement Act
- Last Action
- 6/14/2021
Actions
- 2021-06-14Referred to the Subcommittee on Health.
- 2021-06-11Referred to the Subcommittee on Health.
- 2021-06-11Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-11Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-06-11Introduced in House
- 2021-06-11Introduced in House
CRS Summary
As of 2021-06-11 (00)
Medicare IVIG Access Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services to establish a five-year demonstration project to evaluate the benefits of providing Medicare coverage and payment for items and services needed for the in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy or multifocal motor neuropathy. Beneficiary participation shall be voluntary.
Cosponsors (15)
- CHRISTOPHER SMITH (R-NJ)
- G. K. Butterfield (D-NC)
- Jenniffer Gonzalez-Colon (R-PR)
- Adrian Smith (R-NE)
- John Garamendi (D-CA)
- RON KIND (D-WI)
- Susan Wild (D-PA)
- BOBBY RUSH (D-IL)
- JERROLD NADLER (D-NY)
- Elaine Luria (D-VA)
- JAMES MCGOVERN (D-MA)
- DIANA DEGETTE (D-CO)
- Debbie Lesko (R-AZ)
- Terri Sewell (D-AL)
- Brian Fitzpatrick (R-PA)
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.